Nowe metody i perspektywy leczenia endoskopowego otyłości
Słowa kluczowe:
endoskopowe leczenie otyłości, IGB, ESG, DJBS, terapia aspiracyjnaStreszczenie
Modyfikacje stylu życia i farmakoterapia są w stanie zapewnić jedynie umiarkowane efekty w zakresie utraty wagi. Natomiast większość osób z otyłością dąży do redukcji masy ciała o 15% lub więcej, co zwykle osiąga się tylko dzięki chirurgii bariatrycznej. Operacje bariatryczne, mimo że najskuteczniejsze, wiążą się z najwyższym odsetkiem poważnych powikłań krótko- i długoterminowych. Dlatego nadal istnieje potrzeba opracowania mniej inwazyjnych metod leczenia o podobnej skuteczności klinicznej jak procedury klasycznej chirurgii bariatrycznej. Endoskopowe metody leczenia bariatrycznego, choć stosunkowo nowe, wydają się skuteczną i małoinwazyjną innowacją w leczeniu otyłości. W tej pracy omówiono mechanizmy i ogólne skutki działania najpopularniejszych metod endoskopowego leczenia patologicznie nadmiernej masy ciała oraz perspektywy rozwoju tej dziedziny medycyny.
Rozdziały
-
Nowe metody i perspektywy leczenia endoskopowego otyłości
Bibliografia
World Health Organisation. Obesity and Overweight. World Health Organisation. Published June 9, 2021. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
Nadwaga i otyłość u dorosłych. www.mp.pl. Accessed February 22, 2023. https://www.mp.pl/nadwaga-i-otylosc/wytyczne/246952
Operacje bariatryczne: są nowe wytyczne dot. kwalifikacji do zabiegów. pulsmedycyny.pl. Accessed February 22, 2023. https://pulsmedycyny.pl/operacje-bariatryczne-sa-nowe-wytyczne-dot-kwalifikacji-do-zabiegow-1167427
Estimate of Bariatric Surgery Numbers, 2011-2017 | American Society for Metabolic and Bariatric Surgery. American Society for Metabolic and Bariatric Surgery. Published June 26, 2018. https://asmbs.org/resources/estimate-of-bariatric-surgery-numbers
Angrisani L, Santonicola A, Iovino P, Ramos A, Shikora S, Kow L. Bariatric Surgery Survey 2018: Similarities and Disparities Among the 5 IFSO Chapters. Obesity Surgery. Published online January 12, 2021. doi:https://doi.org/10.1007/s11695-020-05207-7
Courcoulas A, Coley RY, Clark JM, et al. Interventions and Operations 5 Years After Bariatric Surgery in a Cohort From the US National Patient-Centered Clinical Research Network Bariatric Study. JAMA Surgery. 2020;155(3):194. doi:https://doi.org/10.1001/jamasurg.2019.5470
Mathus-Vliegen EMH, de Groot GH. Fasting and Meal-Induced CCK and PP Secretion Following Intragastric Balloon Treatment for Obesity. Obesity Surgery. 2012;23(5):622-633. doi:https://doi.org/10.1007/s11695-012-0834-6
Laing P, Pham T, Taylor LJ, Fang J. Filling the Void: A Review of Intragastric Balloons for Obesity. Digestive Diseases and Sciences. 2017;62(6):1399-1408. doi:https://doi.org/10.1007/s10620-017-4566-2
Glass J, Chaudhry A, Zeeshan MS, Ramzan Z. New Era: Endoscopic treatment options in obesity–a paradigm shift. World Journal of Gastroenterology. 2019;25(32):4567-4579. doi:https://doi.org/10.3748/wjg.v25.i32.4567
Abu Dayyeh BK, Edmundowicz SA, Jonnalagadda S, et al. Endoscopic bariatric therapies. Gastrointestinal Endoscopy. 2015;81(5):1073-1086. doi:https://doi.org/10.1016/j.gie.2015.02.023
Genco A, Maselli R, Frangella F, et al. Intragastric balloon for obesity treatment: results of a multicentric evaluation for balloons left in place for more than 6 months. Surgical Endoscopy. 2015;29(8):2339-2343. doi:https://doi.org/10.1007/s00464-014-3957-0
Ashrafian H, Monnich M, Braby TS, Smellie J, Bonanomi G, Efthimiou E. Intragastric balloon outcomes in super-obesity: a 16-year city center hospital series. Surgery for Obesity and Related Diseases. 2018;14(11):1691-1699. doi:https://doi.org/10.1016/j.soard.2018.07.010
Kotzampassi K, Grosomanidis V, Papakostas P, Penna S, Eleftheriadis E. 500 intragastric balloons: what happens 5 years thereafter? Obesity Surgery. 2012;22(6):896-903. doi:https://doi.org/10.1007/s11695-012-0607-2
Ways to Lose Weight Without Surgery | Learn About Gastric Balloon. Orbera.com. Published 2022. Accessed February 22, 2023. https://www.orbera.com/uk-ireland/about-orbera
Ponce J, Woodman G, Swain J, et al. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surgery for Obesity and Related Diseases. 2015;11(4):874-881. doi:https://doi.org/10.1016/j.soard.2014.12.006
Agnihotri A, Xie A, Bartalos C, et al. Real-World Safety and Efficacy of Fluid-Filled Dual Intragastric Balloon for Weight Loss. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association. 2018;16(7):1081-1088.e1. doi:https://doi.org/10.1016/j.cgh.2018.02.026
Weight M. Orbera® Managed Weight Loss System. Orbera.com. Published 2018. Accessed February 22, 2023. https://www.orbera.com/reshape/
Health C for D and R. UPDATE: Potential Risks with Liquid-filled Intragastric Balloons - Letter to Health Care Providers. FDA. Published online August 22, 2022. Accessed February 22, 2023.
Stavrou G, Shrewsbury A, Kotzampassi K. Six intragastric balloons: Which to choose? World Journal of Gastrointestinal Endoscopy. 2021;13(8):238-259. doi:https://doi.org/10.4253/wjge.v13.i8.238
Sullivan S, Swain J, Woodman G, et al. Randomized sham-controlled trial of the 6-month swallowable gas-filled intragastric balloon system for weight loss. Surgery for Obesity and Related Diseases. 2018;14(12):1876-1889. doi:https://doi.org/10.1016/j.soard.2018.09.486
Genco A, Dellepiane D, Baglio G, et al. Adjustable intragastric balloon vs non-adjustable intragastric balloon: case-control study on complications, tolerance, and efficacy. Obesity Surgery. 2013;23(7):953-958. doi:https://doi.org/10.1007/s11695-013-0891-5
Machytka E, Klvana P, Kornbluth A, et al. Adjustable intragastric balloons: a 12-month pilot trial in endoscopic weight loss management. Obesity Surgery. 2011;21(10):1499-1507. doi:https://doi.org/10.1007/s11695-011-0424-z
Health C for D and R. Spatz3 Adjustable Balloon System - P190012. FDA. Published online May 12, 2022. https://www.fda.gov/medical-devices/recently-approved-devices/spatz3-adjustable-balloon-system-p190012
Choi SJ, Choi HS. Various Intragastric Balloons Under Clinical Investigation. Clinical Endoscopy. 2018;51(5):407-415. doi:https://doi.org/10.5946/ce.2018.140
Jamal MH, Almutairi R, Elabd R, AlSabah SK, Alqattan H, Altaweel T. The Safety and Efficacy of Procedureless Gastric Balloon: a Study Examining the Effect of Elipse Intragastric Balloon Safety, Short and Medium Term Effects on Weight Loss with 1-Year Follow-Up Post-removal. Obesity Surgery. 2019;29(4):1236-1241. doi:https://doi.org/10.1007/s11695-018-03671-w
Ienca R, Al Jarallah M, Caballero A, et al. The Procedureless Elipse Gastric Balloon Program: Multicenter Experience in 1770 Consecutive Patients. Obesity Surgery. 2020;30(9):3354-3362. doi:https://doi.org/10.1007/s11695-020-04539-8
Usuy E, Brooks J. Response Rates with the Spatz3 Adjustable Balloon. Obesity Surgery. 2017;28(5):1271-1276. doi:https://doi.org/10.1007/s11695-017-2994-x
Genco A, Ernesti I, Ienca R, et al. Safety and Efficacy of a New Swallowable Intragastric Balloon Not Needing Endoscopy: Early Italian Experience. Obesity Surgery. 2018;28(2):405-409. doi:https://doi.org/10.1007/s11695-017-2877-1
Machytka E, Chuttani R, Bojkova M, et al. ElipseTM, a Procedureless Gastric Balloon for Weight Loss: a Proof-of-Concept Pilot Study. Obesity Surgery. 2015;26(3):512-516. doi:https://doi.org/10.1007/s11695-015-1783-7
Espinet-Coll E, Nebreda-Durán J, Gómez-Valero JA, et al. Current endoscopic techniques in the treatment of obesity. Revista Espanola De Enfermedades Digestivas. 2012;104(2):72-87. doi:https://doi.org/10.4321/s1130-01082012000200006
Giardiello C, Borrelli A, Silvestri E, Antognozzi V, Iodice G, Lorenzo M. Air-filled vs water-filled intragastric balloon: a prospective randomized study. Obesity Surgery. 2012;22(12):1916-1919. doi:https://doi.org/10.1007/s11695-012-0786-x
Trande P, Mussetto A, Mirante VG, et al. Efficacy, tolerance and safety of new intragastric air-filled balloon (Heliosphere BAG) for obesity: the experience of 17 cases. Obesity Surgery. 2010;20(9):1227-1230.
doi:https://doi.org/10.1007/s11695-008-9786-2
Forestieri P, De Palma GD, Formato A, et al. Heliosphere Bag in the treatment of severe obesity: preliminary experience. Obesity Surgery. 2006;16(5):635-637. doi:https://doi.org/10.1381/096089206776945156
Mion F, Gincul R, Roman S, et al. Tolerance and efficacy of an air-filled balloon in non-morbidly obese patients: results of a prospective multicenter study. Obesity Surgery. 2007;17(6):764-769. doi:https://doi.org/10.1007/s11695-007-9141-z
Kumar N. Endoscopic therapy for weight loss: Gastroplasty, duodenal sleeves, intragastric balloons, and aspiration. World Journal of Gastrointestinal Endoscopy. 2015;7(9):847. doi:https://doi.org/10.4253/wjge.v7.i9.847
Tsesmeli N, Coumaros D. Review of endoscopic devices for weight reduction: old and new balloons and implantable prostheses. Endoscopy. 2009;41(12):1082-1089. doi:https://doi.org/10.1055/s-0029-1215269
Lecumberri E, Krekshi W, Matía P, et al. Effectiveness and safety of air-filled balloon Heliosphere BAG® in 82 consecutive obese patients. Obesity Surgery. 2011;21(10):1508-1512. doi:https://doi.org/10.1007/s11695-010-0314-9
Abu Dayyeh BK, Acosta A, Camilleri M, et al. Endoscopic Sleeve Gastroplasty Alters Gastric Physiology and Induces Loss of Body Weight in Obese Individuals. Clinical Gastroenterology and Hepatology. 2017;15(1):37-43.e1. doi:https://doi.org/10.1016/j.cgh.2015.12.030
Abu Dayyeh BK, Bazerbachi F, Vargas EJ, et al. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial. Lancet (London, England). 2022;400(10350):441-451. doi:https://doi.org/10.1016/S0140-6736(22)01280-6
Sullivan S, Swain JM, Woodman G, et al. Randomized sham-controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: The ESSENTIAL trial. Obesity (Silver Spring, Md). 2017;25(2):294-301. doi:https://doi.org/10.1002/oby.21702
Kumar N, Sullivan S, Thompson C. The role of endoscopic therapy in obesity management: intragastric balloons and aspiration therapy. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2017;Volume 10:311-316. doi:https://doi.org/10.2147/dmso.s95118
Thompson CC, Abu Dayyeh BK, Kushner R, et al. Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial. The American Journal of Gastroenterology. 2017;112(3):447-457. doi:https://doi.org/10.1038/ajg.2016.500
Chirurgia po Dyplomie - Nowe metody endoskopowego leczenia otyłości olbrzymiej. podyplomie.pl. Accessed February 23, 2023. https://podyplomie.pl/chirurgia/15762
Glass J, Chaudhry A, Zeeshan MS, Ramzan Z. New Era: Endoscopic treatment options in obesity–a paradigm shift. World Journal of Gastroenterology. 2019;25(32):4567-4579. doi:https://doi.org/10.3748/wjg.v25.i32.4567
Abu Dayyeh BK, Kumar N, Edmundowicz SA, et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointestinal Endoscopy. 2015;82(3):425-438.e5. doi:https://doi.org/10.1016/j.gie.2015.03.1964
de Jonge C, Rensen SS, Verdam FJ, et al. Endoscopic Duodenal–Jejunal Bypass Liner Rapidly Improves Type 2 Diabetes. Obesity Surgery. 2013;23(9):1354-1360. doi:https://doi.org/10.1007/s11695-013-0921-3
Knop FK. Resolution of type 2 diabetes following gastric bypass surgery: involvement of gut-derived glucagon and glucagonotropic signalling? Diabetologia. 2009;52(11):2270-2276. doi:https://doi.org/10.1007/s00125-009-1511-8
van Rijn S, Roebroek YGM, de Jonge C, Greve JWM, Bouvy ND. Effect of the EndoBarrier Device: a 4-Year Follow-up of a Multicenter Randomized Clinical Trial. Obesity Surgery. 2019;29(4):1117-1121. doi:https://doi.org/10.1007/s11695-018-03659-6
Opublikowane
9 maja 2023
Prawa autorskie (c) 2023 Małgorzata Stopyra, Natalia Nafalska, Patrycja Pabis, Radosław Szydłowski
Licencja
Utwór dostępny jest na licencji Creative Commons Uznanie autorstwa – Użycie niekomercyjne – Bez utworów zależnych 4.0 Międzynarodowe.
